Lupus Research Alliance News
The Patients’ Voice Heard at LUPUS 2019

April 11, 2019 The Lupus Research Alliance is pleased to report on an inspirational talk our fellow colleague and good friend Kathleen Arntsen, President & CEO of Lupus and Allied Diseases Association, Inc. (LADA) gave at the recent 13th International Congress on Systemic Lupus Erythematosus. Called LUPUS 2019, the meeting was an opportunity for researchers, […] READ MORE

Updates in Lupus Clinical Research from the LUPUS 2019 Meeting

April 11, 2019 The Lupus Research Alliance is pleased to share the results from four clinical trials presented at LUPUS 2019.  These studies continue to push our way forward toward new and improved treatments to help the lupus community. There’s a Silver Lining in New Belimumab Results Jim Oates, MD, Medical University of South Carolina, […] READ MORE

New Treatment Approaches Supported by LRA Were Highlighted at LUPUS 2019

April 11, 2019 The bacteria that cause urinary tract infections may trigger lupus flares, a former Alzheimer’s disease therapy has shown promising results in research models—these are just some of the findings presented by Lupus Research Alliance-funded scientists at the 13th International Congress on Systematic Lupus Erythematosus (LUPUS 2019), held in San Francisco. Here are […] READ MORE

New Guidelines for Lupus Treatment From EULAR

April 10, 2019 New recommendations for treating systemic lupus erythematosus were just issued by EULAR – the European League Against Rheumatism (EULAR) and published in Annals of the Rheumatic Diseases . A group of researchers from 29 medical centers across Europe reviewed all the current literature on lupus treatment to formulate questions, elicit expert opinions […] READ MORE

Forum for Discovery

April, 2019 In November, top-flight research scientists, pharmaceutical industry representatives, and advocates met in New York City to take part in the Forum for Discovery on November 28th – 30th, 2018. This annual scientific conference is orchestrated by the Lupus Research Alliance. More than 20 Lupus Research Alliance-funded investigators described their latest research in detail, […] READ MORE

Seeing Our Research Through a Fresh Lens With Dr. Gary Koretzky

April, 2019 The Lupus Research Alliance is proud to welcome renowned expert in rheumatology and immunology, Gary Koretzky, MD, PhD, as co-chair of our Scientific Advisory Board (SAB). He will co-chair the SAB with the distinguished Dr. Mary “Peggy” Crow. Dr. Crow is Physician-in-Chief and Chair of the Department of Medicine at Hospital for Special […] READ MORE

A Promising New Therapy

April, 2019 As our name implies, the Lupus Research Alliance aims to forge partnerships and bring other players  to the table to better understand and treat lupus — and our latest venture holds the promise of a new therapy. We — and our affiliate, Lupus Therapeutics — are about to collaborate with Takeda Pharmaceutical Company […] READ MORE

Taking Scientific Discovery: From Lab Bench to You

April, 2019 Making new and efficacious lupus therapies available to patients has long been a major focus of the Lupus Research Alliance, and today we’ve taken an important step toward that aim. Based on a breakthrough discovery made by Betty Diamond, MD of Feinstein Institutes for Medical Research, Meggan Mackay, MD, MS, also at Feinstein, will […] READ MORE

Thank You Congress for Hearing Our Lupus Advocates!

March 28, 2019 Thank you to the Congressional Lupus Caucus Co-chairs for leading, and to all the Representatives who signed on to a letter  to the House Appropriations Committee asking for increased funding to support critically important lupus research programs in FY 2020. Kudos to our advocates who urged legislators online and in person to […] READ MORE

Lupus Research Alliance Earns Coveted 4-Star Rating from Charity Navigator

NEW YORK, NY. March 28 – Lupus Research Alliance earned a 4-star rating from Charity Navigator, America’s largest independent charity evaluator. Awarded for its strong financial health and commitment to accountability and transparency, the Lupus Research Alliance has earned this distinction every year since its founding in 2016.   Using objective analysis, Charity Navigator has […] READ MORE

LRA Funding Helps Identify Uncontrolled Blood Pressure as Particular Risk in Lupus

March, 2019 New results partially funded by the Lupus Research Alliance found that people with systemic lupus erythematosus have almost double the risk for a dangerous condition, resistant hypertension (RHTN) than those without the disease. RHTN is defined as blood pressure that either remains high despite treatment with three anti-hypertensive medications or is controlled only […] READ MORE

Together, ManyOne Can make a difference!
Stay informed about events, research developments, and ways you can help. Sign up for updates